An investigation into the mechanisms which underpin the modulation of immune responses by aggregation of biotherapeutic drugs
An investigation into the mechanisms which underpin the modulation of immune responses by aggregation of biotherapeutic drugs
批准号:
1908813
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
生物药物,特别是单克隆抗体(MAb),广泛用于医学中以治疗一系列病症,包括恶性疾病和一系列炎性病症。虽然单克隆抗体被设计成含有人类序列,但这些药物经常会引起免疫反应,产生抗药抗体,反过来又会阻断药物作用,或者在某些情况下,给患者带来更严重的医疗并发症。生物制药能够打破自身耐受性的原因尚不清楚,但一个促成因素是聚集-形成不同大小(nm至um范围)的无定形、不规则蛋白质颗粒。该提议基于我们最近发表的观察结果,即聚集导致小鼠模型中的Th 1偏斜免疫应答(Ratanji et al. Toxicological Sciences 2016)。我们将从两个方面扩展这些观察。首先,我们需要扩展我们的研究,以涵盖我们迄今为止研究的蛋白质以外的更广泛的蛋白质。这将包括更能代表临床使用的药物的生物素蛋白。其次,我们将研究支持这种反应的分子机制,重点关注聚集对抗原呈递细胞(APC),来自标准细胞系(THP-1)或分化的人外周血单核细胞的蛋白质识别,内化,加工和呈递的影响。
英文摘要
Biopharmaceuticals, particularly monoclonal antibodies (MAbs), are widely used in medicine to treat a range of conditions, including malignant disease and a range of inflammatory conditions. Although MAbs are engineered to contain human sequences, these drugs can frequently elicit immune responses resulting in anti-drug antibodiesthat can, in turn, block drug action or, in some cases, give rise to more serious medical complications for the patient. The reasons why biopharmaceuticals have the ability to break self-tolerance are not well understood, but a contributory factor is aggregation- the formation of amorphous, irregular protein particles of varying sizes (nm to um range). This proposal builds on our recently published observation that aggregation causes a Th1-skewed immune response in a mouse model (Ratanji et al. Toxicological Sciences 2016). We will expand these observations in two ways. First, we need to extend our studies to embrace a wider range of proteins beyond those which we have studied to date. This will include biotherapeutic proteins which are more representative of drugs in clinical use. Second, we will investigate the molecular mechanisms which underpin this response, focusing on the influence of aggregation on the recognition, internalisation, processing and presentation of proteins by antigen presenting cells (APCs), derived from standard cell lines (THP-1), or from differentiated human peripheral blood monocytes .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金